Navigation Links
EpiCept Reports Second Quarter 2013 Operating and Financial Results
Date:7/31/2013

of Operations Data(in $000s except share and per share data)Three Months Ended June 30,Six Months Ended June 30,2013201220132012Product net revenues$
8212;$
577$
283$
583Licensing and other revenues996,0251926,260Total revenue996,6024756,843Costs and expenses:Cost of goods sold

396143

396Selling, general and administrative

927

1,3841,737

2,815Research and development

681

9631,011

2,259Total costs and expenses

1,608

2,7432,891

5,470Income (loss) from operations

(1,509)

3,859(2,416)

1,373Other income (expense):Interest income

1—

3Foreign exchange loss

(521)—

(264)Warrant amendment expense

——

(936)Interest expense

(175)

(380)(363)

(743)Other income (expense), net

(175)

(900)(363)

(1,940)Net income (loss) before income taxes(1,684)2,959(2,779)(567)Income taxes

—(5)

(2)Net income (loss )$
(1,684)$
2,959$
(2,784)$
(569)Deemed dividends on convertible preferred stock

(750)—

(1,926)Income (loss) attributable to common stockholders $
(1,684)

$
2,209
$
(2,784)

$
(2,495)
Basic and diluted income (loss) per common share

$
(0.01)

$
.03
$
(0.03)

$
(0.03)
Weighted average shares - Basic

113,639,424

83,772,960110,158,277

80,414,692Weighted average shares - Diluted

113,639,424

91,591,893110,158,277

80,414,692EpiCe
'/>"/>

SOURCE EpiCept Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
2. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
3. Interleukin Genetics Reports Third Quarter 2011 Financial Results
4. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
5. Nile Therapeutics Reports 2011 Third Quarter Financial Results
6. Pharmasset Reports Fiscal Year End 2011 Financial Results
7. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
8. SeraCare Reports Fiscal Year 2011 and Fourth Quarter Financial Results
9. WaferGen Reports Third Quarter 2011 Financial Results and Announces New Commercialization Strategy
10. Hadasit Bio-Holdings Ltd. Reports Significant External Financing for Portfolio Companies
11. Biodel Reports Fourth Quarter Fiscal Year 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... December 19, 2014 BioPlus Specialty ... pharmacies, announces the promotion of Nick Maroulis, Pharm.D. to ... Pharmacy Services. , In this position, Dr. Maroulis ... also managing the directors of our multi-site pharmacies as ... since 1997 and during that time he has served ...
(Date:12/19/2014)... PLEASANTON, Calif. , Dec. 19, 2014  Roche ... acquisition of Bina Technologies, Inc. (Bina), a privately ... California , USA. Bina provides a big ... next generation sequencing (NGS) data. Bina,s proprietary on-market ... translational and academic researchers to perform fast and ...
(Date:12/19/2014)... -- Decision Resources Group finds that the Latin American ... compound annual growth rate through 2023. This is primarily ... increasing adoption of dental implants. Growing aesthetic consciousness in ... demand for dental biomaterials because they can improve the ... Other key findings from Decision Resources Group,s coverage ...
(Date:12/19/2014)... 2014 BioPlus Specialty Pharmacy ... pharmacies, has an expanded team of Regional Pharmaceutical ... for prescriber offices in their regions, with specific ... have a variety of Regional Pharmaceutical Care Liaisons ... in hepatitis C help prescribers understand all the ...
Breaking Biology Technology:BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Roche acquires Bina Technologies and enters the genomic informatics market 2Roche acquires Bina Technologies and enters the genomic informatics market 3Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 3BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 2BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 3
... 9 Campbell Alliance, the leading management consulting ... today announced that Joe Dillon has joined its ... closely with the Business Development Practice to help ... develop comprehensive strategies related to in- and out-licensing, ...
... Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) ... Cowen and Company 29th Annual Health Care Conference on ... the Boston Marriott Copley Place.A live webcast and archived ... the Investor Relations section of Peregrine,s website at ...
... INDIANAPOLIS, March 9 BioStorage Technologies, Inc. (BST), a ... sample management and cold chain logistics, announces the recent ... of Senior Vice President.Ball joined BioStorage Technologies in 2007 ... she led worldwide sales as well as corporate branding ...
Cached Biology Technology:Campbell Alliance Hires Joe Dillon, Expands Business Development Practice 2Campbell Alliance Hires Joe Dillon, Expands Business Development Practice 3BioStorage Technologies, Inc. Promotes Lori Ball to Senior Vice President and Expands Role 2
(Date:12/11/2014)... 10, 2014  That blood pressure plays a role in ... – the medical term for high blood pressure – was ... the inflatable cuff that,s used in measuring blood pressure was ... nothing new about hypertension, its triggers and its effects. In ... condition and the best ways to treat it. ...
(Date:12/10/2014)... You,ve been here before: you desperately need to sign into ... key or the answer to your secret question. What,s your ... Today, Hoyos Labs , a digital infrastructure security ... an end to the frustration that comes with usernames, passwords ... a user,s smartphone to acquire his or her biometrics to ...
(Date:12/10/2014)... WINSTON-SALEM, N.C. , Dec. 9, 2014  Wake Forest ... medical education building for its School of Medicine. Funding ... a larger capital campaign that will be publicly launched ... will be located in the former 60 series R.J. ... Forest Innovation Quarter. Construction will begin immediately with plans ...
Breaking Biology News(10 mins):Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
... raise the offspring of others seems like a bad ... starlings have adopted this strategy to deal with the ... new study by University of California, Berkeley, and Cornell ... of the journal Current Biology. This behavior, called ...
... at Cure Lab, Inc., a biotechnology company based in ... and Harvard Medical School have discovered a potential new ... those that may be effective against potentially pandemic influenza ... in the August 15, 2007 issue of the journal ...
... Obesity and aversion to exercise have become hallmarks of ... blood protein linked to these lifestyle factors may be an ... from the Dana Farber Cancer Institute report their findings in ... the American Association for Cancer Research. In a ...
Cached Biology News:Savanna habitat drives birds, and perhaps others, to cooperative breeding 2Savanna habitat drives birds, and perhaps others, to cooperative breeding 3Savanna habitat drives birds, and perhaps others, to cooperative breeding 4New target for anti-flu drug development 2Obesity and lack of exercise could enhance the risk of pancreatic cancer 2
... to significantly increase the shelf life of ... increased at room temperature storage conditions in ... is subjected to 0.45 micron filtration, and ... formulation insures consistently high levels of activity ...
... I provides a convenient and affordable alternative ... Used with an eight-port disposable manifold, the ... with multi-channel pipettes. The eight-port manifold, designed ... of 100, 200, 250, or 300mL with ...
...
... Frame products feature a dual strength adhesive system ... after use. The adhesives on either side of ... which adheres to the glass has an easy ... the coverslip, forms a stronger bond. This means ...
Biology Products: